Persistence of hepatitis B virus DNA after eduction of viral replication in serum and liver
Molina J, Bartolomé J, Moraleda G, Ruiz-Moreno M, Rúa MJ, Moreno A,Carreño V. J Med Virol 1992; 38: 11-15.
An escalating dose regime of recombinant interpheron-alpha 2A in the treatment of chronic hepatitis C.
Bosch O, Tapia L, Quiroga JA,Carreño V. J Hepatol 1993; 17: 146-149.
Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B
Ruiz-Moreno M, Rúa MJ, Moraleda G, Guardia L, Moreno A,Carreño V. Pediatrics 1992; 90: 254-258.
Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.
Quiroga JA, Bosch O, Gonzalez R, Marriott E, Castillo I, Bartolomé J,Carreño V. Gastroenterology 1992; 103: 1285-1289.
Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy.
Carreño V, Castillo I, Molina J, Porres JC, Bartolomé J. J Hepatol 1992; 15: 102-106.
Increase in triglicerides during alpha interferon treatment of chronic viral hepatitis.
Ruíz-Moreno M,Carreño V, Rúa MJ, Cotonat T, Serrano B, Santos M, Marriott E. J Hepatol 1992; 16: 384.
Re-Treatment of chronic hepatitis C with alpha-interferon.
Marriott E, Quiroga JA,Carreño V. J Infect Dis 1992; 166: 1200-1.
Positive ELISA-2 is pathologically relevant in ELISA-1-negative patients on hemodialysis.
Caramelo C,Carreño V, González-Parra E, Quiroga JA, Garrón MP, Marriott E, Ortíz A, Galera A, López MD, Porres JC. Nephron 1992; 61: 474.
Comparison of several PCR procedures for detection of HCV RNA using different regions of the HCV genome
Castillo I, Bartolomé J, Quiroga JA,Carreño V. J Virol Methods 1992; 38: 71-80.
Treatment of children with chronic hepatitis C with recombinant alpha interferon: a pilot study.
Ruiz-Moreno M, Rúa MJ, Castillo I, García-Novo MD, Santos M, Navas S,Carreño V. Hepatology 1992; 16: 882-885.
Virus de la hepatitis C y crioglobulinemia.
Ortiz A, Quiroga JA, García Delgado R,Carreño V, Caramelo C. Rev Clín Esp 1992; 190: 157.
Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
Carreño V, Tapia L, Ryff JC, Quiroga JA, Castillo I. J Med Virol 1992; 37: 215-219.
